1-3 of 3
Khawla Belhoul
Close
Sort by
Journal Articles

Deferasirox Compared With Deferoxamine For The Removal Of Cardiac Iron In Patients With β-Thalassemia Major: 2-Year Data From The Cordelia Extension

Dudley J Pennell, MD, John B Porter, MD, Antonio Piga, MD, Yongrong Lai, MD, Amal El-Beshlawy, MD, Khawla Belhoul, MD, Mohsen Elalfy, MD, Akif Yesilipek, MD, Yurdanur Kilinç, MD, Antje Wegener, MD, Dany Habr, MD, Junwu Shen, PhD, Yesim Aydinok, MD
Journal: Blood
Blood (2013) 122 (21): 1018.
https://doi.org/10.1182/blood.V122.21.1018.1018
Published: 2013
Journal Articles

Risk Factors for Pulmonary Hypertension In Patients with Thalassemia Intermedia

Mehran Karimi, MD, Khaled M Musallam, MD, Maria Domenica Cappellini, MD, Amal El-Beshlawy, MD, Khawla Belhoul, MD, Shahina Daar, MD, Mohamed-SalahEldin Saned, MD, Sally Temraz, MD, Ali T Taher, MD
Journal: Blood
Blood (2010) 116 (21): 2069.
https://doi.org/10.1182/blood.V116.21.2069.2069
Published: 2010
Journal Articles

Overview on practices in thalassemia intermedia management aiming for lowering complication rates across a region of endemicity: the OPTIMAL CARE study

Clinical Trials & Observations
Ali T. Taher, Khaled M. Musallam, Mehran Karimi, Amal El-Beshlawy, Khawla Belhoul, Shahina Daar, Mohamed-SalahEldin Saned, Abdul-Hamid El-Chafic, Maria R. Fasulo, Maria D. Cappellini
Journal: Blood
Blood (2010) 115 (10): 1886–1892.
https://doi.org/10.1182/blood-2009-09-243154
Published: 2010